Source link : https://newshealth.biz/health-news/new-tyk2-inhibitors-for-psoriasis-achieve-high-clearance-rates-in-randomized-trials/
DENVER — Two drug candidates to expand oral therapy options for psoriasis had similar and consistent performances in separate phase III clinical trials reported here. The allosteric TYK2 inhibitor zasocitinib achieved at least 75% improvement in the psoriasis area and severity index (PASI 75) and physician-rated clear or almost clear skin (physician global assessment [PGA] […]
The post New TYK2 Inhibitors for Psoriasis Achieve High Clearance Rates in Randomized Trials first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-01 21:45:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8